446 related articles for article (PubMed ID: 24945369)
41. Effects of the Bragg peak degradation due to lung tissue in proton therapy of lung cancer patients.
Baumann KS; Flatten V; Weber U; Lautenschläger S; Eberle F; Zink K; Engenhart-Cabillic R
Radiat Oncol; 2019 Oct; 14(1):183. PubMed ID: 31653229
[TBL] [Abstract][Full Text] [Related]
42. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
43. Modulation of lateral positions of Bragg peaks via magnetic fields inside cancer patients: Toward magnetic field modulated proton therapy.
Shao W; Tang X; Bai Y; Geng C; Shu D; Gong C; Chen D
Med Phys; 2017 Oct; 44(10):5325-5338. PubMed ID: 28696514
[TBL] [Abstract][Full Text] [Related]
44. Effects of minimum monitor unit threshold on spot scanning proton plan quality.
Howard M; Beltran C; Mayo CS; Herman MG
Med Phys; 2014 Sep; 41(9):091703. PubMed ID: 25186378
[TBL] [Abstract][Full Text] [Related]
45. Proton beams to replace photon beams in radical dose treatments.
Suit H; Goldberg S; Niemierko A; Trofimov A; Adams J; Paganetti H; Chen GT; Bortfeld T; Rosenthal S; Loeffler J; Delaney T
Acta Oncol; 2003; 42(8):800-8. PubMed ID: 14968940
[TBL] [Abstract][Full Text] [Related]
46. GATE as a GEANT4-based Monte Carlo platform for the evaluation of proton pencil beam scanning treatment plans.
Grevillot L; Bertrand D; Dessy F; Freud N; Sarrut D
Phys Med Biol; 2012 Jul; 57(13):4223-44. PubMed ID: 22684098
[TBL] [Abstract][Full Text] [Related]
47. Experimental characterization of two-dimensional pencil beam scanning proton spot profiles.
Lin L; Ainsley CG; McDonough JE
Phys Med Biol; 2013 Sep; 58(17):6193-204. PubMed ID: 23948730
[TBL] [Abstract][Full Text] [Related]
48. Application of the pencil-beam redefinition algorithm in heterogeneous media for proton beam therapy.
Egashira Y; Nishio T; Hotta K; Kohno R; Uesaka M
Phys Med Biol; 2013 Feb; 58(4):1169-84. PubMed ID: 23370731
[TBL] [Abstract][Full Text] [Related]
49. Development of porous structure for broadening Bragg-peak in scanning carbon-ion radiotherapy: Monte Carlo simulation and experimental validation.
Dong S; Sun J; Ming X; Weber U; Schuy C; Hu W; Sheng Y
Phys Med; 2024 Apr; 120():103325. PubMed ID: 38493583
[TBL] [Abstract][Full Text] [Related]
50. Collimated proton pencil-beam scanning for superficial targets: impact of the order of range shifter and aperture.
Bäumer C; Janson M; Timmermann B; Wulff J
Phys Med Biol; 2018 Apr; 63(8):085020. PubMed ID: 29553047
[TBL] [Abstract][Full Text] [Related]
51. Contour scanning, multi-leaf collimation and the combination thereof for proton pencil beam scanning.
Winterhalter C; Meier G; Oxley D; Weber DC; Lomax AJ; Safai S
Phys Med Biol; 2018 Dec; 64(1):015002. PubMed ID: 30523928
[TBL] [Abstract][Full Text] [Related]
52. Immobilization considerations for proton radiation therapy.
Wroe AJ; Bush DA; Slater JD
Technol Cancer Res Treat; 2014 Jun; 13(3):217-26. PubMed ID: 24066953
[TBL] [Abstract][Full Text] [Related]
53. The influence of physical wedges on penumbra and in-field dose uniformity in ocular proton beams.
Baker C; Kacperek A
Phys Med; 2016 Apr; 32(4):612-7. PubMed ID: 26988936
[TBL] [Abstract][Full Text] [Related]
54. Validation of new 2D ripple filters in proton treatments of spherical geometries and non-small cell lung carcinoma cases.
Ringbæk TP; Weber U; Santiago A; Iancu G; Wittig A; Grzanka L; Bassler N; Engenhart-Cabillic R; Zink K
Phys Med Biol; 2018 Dec; 63(24):245020. PubMed ID: 30523868
[TBL] [Abstract][Full Text] [Related]
55. A beam source model for scanned proton beams.
Kimstrand P; Traneus E; Ahnesjö A; Grusell E; Glimelius B; Tilly N
Phys Med Biol; 2007 Jun; 52(11):3151-68. PubMed ID: 17505095
[TBL] [Abstract][Full Text] [Related]
56. TOPAS Simulation of the Mevion S250 compact proton therapy unit.
Prusator M; Ahmad S; Chen Y
J Appl Clin Med Phys; 2017 May; 18(3):88-95. PubMed ID: 28444840
[TBL] [Abstract][Full Text] [Related]
57. Impact of varying planning parameters on proton pencil beam scanning dose distributions in four commercial treatment planning systems.
Alshaikhi J; Doolan PJ; D'Souza D; Holloway SM; Amos RA; Royle G
Med Phys; 2019 Mar; 46(3):1150-1162. PubMed ID: 30632173
[TBL] [Abstract][Full Text] [Related]
58. Distributions of secondary particles in proton and carbon-ion therapy: a comparison between GATE/Geant4 and FLUKA Monte Carlo codes.
Robert C; Dedes G; Battistoni G; Böhlen TT; Buvat I; Cerutti F; Chin MP; Ferrari A; Gueth P; Kurz C; Lestand L; Mairani A; Montarou G; Nicolini R; Ortega PG; Parodi K; Prezado Y; Sala PR; Sarrut D; Testa E
Phys Med Biol; 2013 May; 58(9):2879-99. PubMed ID: 23571094
[TBL] [Abstract][Full Text] [Related]
59. Exploring the feasibility of a clinical proton beam with an adaptive aperture for pre-clinical research.
Almeida IP; Vaniqui A; Schyns LE; van der Heyden B; Cooley J; Zwart T; Langenegger A; Verhaegen F
Br J Radiol; 2019 Mar; 92(1095):20180446. PubMed ID: 30362812
[TBL] [Abstract][Full Text] [Related]
60. Small field proton irradiation for in vivo studies: Potential and limitations when adapting clinical infrastructure.
Clausen M; Ruangchan S; Sotoudegan A; Resch AF; Knäusl B; Palmans H; Georg D
Z Med Phys; 2023 Nov; 33(4):542-551. PubMed ID: 36357294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
